Trial site

Fortrea Clinical Research Unit

Daytona Beach, Florida 32117, United StatesNot linked to an institution yet

8running trials
8closed trials

The trials here

What the 16 trials at this site are about, from their registry records.

Conditions: Obesity11 trials
Alzheimer disease3 trials
Type 2 diabetes2 trials
Atopic dermatitis (eczema)1 trial
Rheumatoid arthritis1 trial
Type 1 diabetes1 trial
Phase: Phase 116 trials
Status: Completed7 trials
Recruiting5 trials
Not yet recruiting2 trials
Active, not recruiting1 trial
Terminated1 trial
Lead sponsor: Eli Lilly and Company16 trials

Running trials

Not yet recruiting
A Study of LY4167586 in Participants With Obesity or Overweight With or Without Type 2 Diabetes
NCT07881887· Phase 1· Eli Lilly and Company· Source
Contact: Chiamaka Iheme (principal investigator)
Not yet recruiting
A Study of LY4560736 in Healthy Participants and Participants With Alzheimer's Disease (AD)
NCT07843459· Phase 1· Eli Lilly and Company· Source
Contact: Chiamaka Iheme (principal investigator)
Recruiting
A Study of LY4329090 in Participants With Obesity or Overweight Who Are Otherwise Healthy
NCT07808073· Phase 1· Eli Lilly and Company· Source
Contact: Chiamaka Iheme (principal investigator)
Recruiting
A Study of Eloralintide (LY3841136) in Female Participants With Obesity or Overweight
NCT07808060· Phase 1· Eli Lilly and Company· Source
Contact: Chiamaka Iheme (principal investigator)
Recruiting
A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease
NCT07787169· Phase 1· Eli Lilly and Company· Source
Contact: Chiamaka Iheme (principal investigator)
Recruiting
A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis
NCT07258849· Phase 1· Eli Lilly and Company· Source
Contact: Sharrell Cooper (principal investigator)
Recruiting
A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease
NCT07787182· Phase 1· Eli Lilly and Company· Source
Contact: Chiamaka Iheme (principal investigator)
Active, not recruiting
A Study of LY3537031 in Overweight, Obese, and Healthy Participants
NCT06606106· Phase 1· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Alzheimer disease3 recruiting
Obesity3 recruiting
Rheumatoid arthritis1 recruiting
Type 1 diabetes1 recruiting
Type 2 diabetes1 recruiting

Closed trials

Completed
A Study of LY3549492 in Healthy Participants and Participants With Overweight or Obesity
NCT07232732· Phase 1· Eli Lilly and Company· Source
Completed
A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes
NCT06945419· Phase 1· Eli Lilly and Company· Source
Completed
A Study of Eloralintide (LY3841136) and Eloralintide With Tirzepatide in Participants With Overweight or Obesity
NCT06916065· Phase 1· Eli Lilly and Company· Source
Completed
A Study of LY3532226 in Participants With Obesity
NCT06557356· Phase 1· Eli Lilly and Company· Source
Completed
A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or Overweight
NCT06440980· Phase 1· Eli Lilly and Company· Source
Completed
A Study of LY3841136 in Overweight and Obese Participants
NCT06345066· Phase 1· Eli Lilly and Company· Source
Terminated
A Study of LY3872386 in Healthy Participants and Participants With Atopic Dermatitis
NCT06119529· Phase 1· Eli Lilly and Company· Source
Completed
A Study of LY3841136 in Healthy and Overweight Participants
NCT05295940· Phase 1· Eli Lilly and Company· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error